NCT00876759 Whole-Brain Radiotherapy (WBRT) Versus WBRT and Integrated Boost Using Helical Tomotherapy for Multiple Brain Metastases Status UNKNOWN Phase PHASE2
NCT00854867 Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis. Status COMPLETED Phase PHASE1
NCT00838929 Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases Status COMPLETED Phase PHASE1
NCT00805636 Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. Status UNKNOWN Phase PHASE2
NCT00791063 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT Status COMPLETED Phase PHASE2
NCT00745797 Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy Status TERMINATED Phase PHASE3
NCT00717275 Study of Temozolomide to Treat Newly Diagnosed Brain Metastases Status TERMINATED Phase PHASE2
NCT00663689 Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT00639262 Combination of Sorafenib and Radiation for Brain Metastases and Primary Brain Tumors Status COMPLETED Phase PHASE1
NCT00614978 Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer Status COMPLETED Phase PHASE1
NCT00582075 Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases Status COMPLETED Phase PHASE2
NCT00538343 RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases Status TERMINATED Phase PHASE2
NCT00536861 Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00522951 SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study Status COMPLETED Phase PHASE3
NCT00513162 Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases Status COMPLETED Phase PHASE1
NCT00470847 Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer Status COMPLETED Phase PHASE1
NCT00437957 Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases Status TERMINATED Phase PHASE1